The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global PVA Embolization Particles Market Research Report 2025
Synopsis
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
The global PVA Embolization Particles market was valued at US$ 831 million in 2023 and is anticipated to reach US$ 1186.9 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
North American market for PVA Embolization Particles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for PVA Embolization Particles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of PVA Embolization Particles include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials and Alicon, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PVA Embolization Particles, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PVA Embolization Particles.
Report Scope
The PVA Embolization Particles market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PVA Embolization Particles market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PVA Embolization Particles manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials
Alicon
Segment by Type
Conventional/Irregular PVA
Compressible and Spherical PVA
Segment by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization
Liver Tumor Embolization
Trauma Embolization
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PVA Embolization Particles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PVA Embolization Particles in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
The global PVA Embolization Particles market was valued at US$ 831 million in 2023 and is anticipated to reach US$ 1186.9 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
North American market for PVA Embolization Particles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for PVA Embolization Particles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of PVA Embolization Particles include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials and Alicon, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PVA Embolization Particles, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PVA Embolization Particles.
Report Scope
The PVA Embolization Particles market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PVA Embolization Particles market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PVA Embolization Particles manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials
Alicon
Segment by Type
Conventional/Irregular PVA
Compressible and Spherical PVA
Segment by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization
Liver Tumor Embolization
Trauma Embolization
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PVA Embolization Particles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PVA Embolization Particles in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 PVA Embolization Particles Market Overview
1.1 Product Overview and Scope of PVA Embolization Particles
1.2 PVA Embolization Particles Segment by Type
1.2.1 Global PVA Embolization Particles Market Value Comparison by Type (2024-2030)
1.2.2 Conventional/Irregular PVA
1.2.3 Compressible and Spherical PVA
1.3 PVA Embolization Particles Segment by Application
1.3.1 Global PVA Embolization Particles Market Value by Application: (2024-2030)
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Other
1.4 Global PVA Embolization Particles Market Size Estimates and Forecasts
1.4.1 Global PVA Embolization Particles Revenue 2019-2030
1.4.2 Global PVA Embolization Particles Sales 2019-2030
1.4.3 Global PVA Embolization Particles Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 PVA Embolization Particles Market Competition by Manufacturers
2.1 Global PVA Embolization Particles Sales Market Share by Manufacturers (2019-2024)
2.2 Global PVA Embolization Particles Revenue Market Share by Manufacturers (2019-2024)
2.3 Global PVA Embolization Particles Average Price by Manufacturers (2019-2024)
2.4 Global PVA Embolization Particles Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of PVA Embolization Particles, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PVA Embolization Particles, Product Type & Application
2.7 PVA Embolization Particles Market Competitive Situation and Trends
2.7.1 PVA Embolization Particles Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PVA Embolization Particles Players Market Share by Revenue
2.7.3 Global PVA Embolization Particles Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PVA Embolization Particles Retrospective Market Scenario by Region
3.1 Global PVA Embolization Particles Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global PVA Embolization Particles Global PVA Embolization Particles Sales by Region: 2019-2030
3.2.1 Global PVA Embolization Particles Sales by Region: 2019-2024
3.2.2 Global PVA Embolization Particles Sales by Region: 2025-2030
3.3 Global PVA Embolization Particles Global PVA Embolization Particles Revenue by Region: 2019-2030
3.3.1 Global PVA Embolization Particles Revenue by Region: 2019-2024
3.3.2 Global PVA Embolization Particles Revenue by Region: 2025-2030
3.4 North America PVA Embolization Particles Market Facts & Figures by Country
3.4.1 North America PVA Embolization Particles Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America PVA Embolization Particles Sales by Country (2019-2030)
3.4.3 North America PVA Embolization Particles Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe PVA Embolization Particles Market Facts & Figures by Country
3.5.1 Europe PVA Embolization Particles Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe PVA Embolization Particles Sales by Country (2019-2030)
3.5.3 Europe PVA Embolization Particles Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PVA Embolization Particles Market Facts & Figures by Country
3.6.1 Asia Pacific PVA Embolization Particles Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific PVA Embolization Particles Sales by Country (2019-2030)
3.6.3 Asia Pacific PVA Embolization Particles Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America PVA Embolization Particles Market Facts & Figures by Country
3.7.1 Latin America PVA Embolization Particles Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America PVA Embolization Particles Sales by Country (2019-2030)
3.7.3 Latin America PVA Embolization Particles Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PVA Embolization Particles Market Facts & Figures by Country
3.8.1 Middle East and Africa PVA Embolization Particles Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa PVA Embolization Particles Sales by Country (2019-2030)
3.8.3 Middle East and Africa PVA Embolization Particles Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global PVA Embolization Particles Sales by Type (2019-2030)
4.1.1 Global PVA Embolization Particles Sales by Type (2019-2024)
4.1.2 Global PVA Embolization Particles Sales by Type (2025-2030)
4.1.3 Global PVA Embolization Particles Sales Market Share by Type (2019-2030)
4.2 Global PVA Embolization Particles Revenue by Type (2019-2030)
4.2.1 Global PVA Embolization Particles Revenue by Type (2019-2024)
4.2.2 Global PVA Embolization Particles Revenue by Type (2025-2030)
4.2.3 Global PVA Embolization Particles Revenue Market Share by Type (2019-2030)
4.3 Global PVA Embolization Particles Price by Type (2019-2030)
5 Segment by Application
5.1 Global PVA Embolization Particles Sales by Application (2019-2030)
5.1.1 Global PVA Embolization Particles Sales by Application (2019-2024)
5.1.2 Global PVA Embolization Particles Sales by Application (2025-2030)
5.1.3 Global PVA Embolization Particles Sales Market Share by Application (2019-2030)
5.2 Global PVA Embolization Particles Revenue by Application (2019-2030)
5.2.1 Global PVA Embolization Particles Revenue by Application (2019-2024)
5.2.2 Global PVA Embolization Particles Revenue by Application (2025-2030)
5.2.3 Global PVA Embolization Particles Revenue Market Share by Application (2019-2030)
5.3 Global PVA Embolization Particles Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sirtex Medical
6.1.1 Sirtex Medical Corporation Information
6.1.2 Sirtex Medical Description and Business Overview
6.1.3 Sirtex Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sirtex Medical PVA Embolization Particles Product Portfolio
6.1.5 Sirtex Medical Recent Developments/Updates
6.2 Merit Medical
6.2.1 Merit Medical Corporation Information
6.2.2 Merit Medical Description and Business Overview
6.2.3 Merit Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merit Medical PVA Embolization Particles Product Portfolio
6.2.5 Merit Medical Recent Developments/Updates
6.3 Cook Medical
6.3.1 Cook Medical Corporation Information
6.3.2 Cook Medical Description and Business Overview
6.3.3 Cook Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cook Medical PVA Embolization Particles Product Portfolio
6.3.5 Cook Medical Recent Developments/Updates
6.4 BTG Medical
6.4.1 BTG Medical Corporation Information
6.4.2 BTG Medical Description and Business Overview
6.4.3 BTG Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BTG Medical PVA Embolization Particles Product Portfolio
6.4.5 BTG Medical Recent Developments/Updates
6.5 Boston Scientific Corporation
6.5.1 Boston Scientific Corporation Corporation Information
6.5.2 Boston Scientific Corporation Description and Business Overview
6.5.3 Boston Scientific Corporation PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Boston Scientific Corporation PVA Embolization Particles Product Portfolio
6.5.5 Boston Scientific Corporation Recent Developments/Updates
6.6 Terumo Corporation
6.6.1 Terumo Corporation Corporation Information
6.6.2 Terumo Corporation Description and Business Overview
6.6.3 Terumo Corporation PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Terumo Corporation PVA Embolization Particles Product Portfolio
6.6.5 Terumo Corporation Recent Developments/Updates
6.7 HENGRUI Medical
6.6.1 HENGRUI Medical Corporation Information
6.6.2 HENGRUI Medical Description and Business Overview
6.6.3 HENGRUI Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HENGRUI Medical PVA Embolization Particles Product Portfolio
6.7.5 HENGRUI Medical Recent Developments/Updates
6.8 INterface BIOmaterials
6.8.1 INterface BIOmaterials Corporation Information
6.8.2 INterface BIOmaterials Description and Business Overview
6.8.3 INterface BIOmaterials PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.8.4 INterface BIOmaterials PVA Embolization Particles Product Portfolio
6.8.5 INterface BIOmaterials Recent Developments/Updates
6.9 Alicon
6.9.1 Alicon Corporation Information
6.9.2 Alicon Description and Business Overview
6.9.3 Alicon PVA Embolization Particles Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Alicon PVA Embolization Particles Product Portfolio
6.9.5 Alicon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PVA Embolization Particles Industry Chain Analysis
7.2 PVA Embolization Particles Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PVA Embolization Particles Production Mode & Process
7.4 PVA Embolization Particles Sales and Marketing
7.4.1 PVA Embolization Particles Sales Channels
7.4.2 PVA Embolization Particles Distributors
7.5 PVA Embolization Particles Customers
8 PVA Embolization Particles Market Dynamics
8.1 PVA Embolization Particles Industry Trends
8.2 PVA Embolization Particles Market Drivers
8.3 PVA Embolization Particles Market Challenges
8.4 PVA Embolization Particles Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
